| Entry |
|
|---|
| Name |
Procyclidine (INN) |
|---|
| Formula |
C19H29NO
|
|---|
| Exact mass |
287.2249
|
|---|
| Mol weight |
287.4397
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01745 Anticholinergic antiparkinson agent
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiparkinsonian, Muscarinic acetylcholine receptor antagonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04A ANTICHOLINERGIC AGENTS
N04AA Tertiary amines
N04AA04 Procyclidine
D08425 Procyclidine (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01745 Anticholinergic antiparkinson agent
DG00854 Procyclidine
D08425 Procyclidine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM
D08425 Procyclidine (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01745 Anticholinergic antiparkinson agent
DG00854 Procyclidine
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 21
1 N1y N 21.6300 -19.3200
2 C1b C 22.8200 -18.6200
3 C1b C 24.0800 -19.3200
4 C1d C 25.2700 -18.6200
5 C8y C 26.4600 -19.3200
6 C8x C 27.7200 -18.6200
7 C8x C 28.9100 -19.3200
8 C1x C 20.4400 -18.6200
9 C1x C 19.3900 -19.5300
10 C1x C 19.9500 -20.8600
11 C1x C 21.3500 -20.7200
12 C1y C 25.2700 -17.2200
13 C1x C 26.4600 -16.5200
14 C1x C 26.4600 -15.1200
15 C1x C 25.2700 -14.4200
16 C1x C 24.0800 -15.1200
17 C1x C 24.0800 -16.5200
18 C8x C 26.4600 -20.7200
19 C8x C 27.7200 -21.4200
20 C8x C 28.9100 -20.7200
21 O1a O 26.4600 -17.9200
BOND 23
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 6 7 2
7 1 8 1
8 8 9 1
9 9 10 1
10 10 11 1
11 1 11 1
12 4 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 16 17 1
18 12 17 1
19 5 18 2
20 18 19 1
21 19 20 2
22 20 7 1
23 4 21 1
|
|---|
